Chemistry Nobel's mirror image puzzle: What it means for India and its medicines

Henri B Kagan and Kenso Soai won the 2026 Nobel Prize in Chemistry for showing how a small imbalance between mirror-image molecules can become much larger. Their work concerns asymmetric organic synthesis, which aims to make one molecular form preferentially. This matters because medicines may need one form rather than an equal mixture of both.

Kagan showed that a catalyst’s molecular imbalance can produce a stronger imbalance in the product. In some reactions, matching right-right or left-left helper pairs work, while mismatched pairs work poorly. Soai created a reaction in which the product also acts as a catalyst. It therefore helps make more of its own mirror-image form.

Together, these discoveries gave chemists new ways to control molecular handedness. The article says their importance extends beyond the laboratory, including medicine costs and how young Indian researchers approach chemical problems. Their methods can help when safety, effectiveness, or regulations require a particular molecular form.

Mirror-image molecules have the same atoms joined in the same order, but their three-dimensional arrangements are reflected versions of each other. Because the two forms cannot be placed exactly on top of one another, chemists call them enantiomers. A molecule with this property is chiral, a word derived from the Greek word for hand.

The article compares them with hands. A right hand fits another right hand well, but not a left hand. Carvone provides a familiar example: one mirror-image form smells like spearmint, while its twin smells like caraway. The molecules contain the same atoms, yet their shapes interact differently with receptors.

This difference matters especially in biology. Cells contain structures that can distinguish the two forms. As a result, chemists may need to make one enantiomer preferentially rather than producing an equal mixture. Asymmetric synthesis and catalysts are tools for achieving that control.

A medicine works through interactions with structures in the body, and those structures can distinguish molecular shape. Two enantiomers have identical atoms and connections, but their three-dimensional arrangements differ. One may fit a biological target in the right way and produce the intended effect. Its mirror image may fit weakly, fail to act, or interact with another target.

The article compares this with a handshake. A right hand fits another right hand, but a left hand does not fit the same way. Carvone shows the principle outside medicine: its mirror images produce different smells. The body similarly responds differently to molecular shapes.

This is why chemists may use asymmetric catalysis to favour one form. However, Professor G Sekar warns against treating every drug alike. Thalidomide’s two forms can convert into each other inside the body, so one cannot simply label one safe and the other dangerous. Safety, efficacy, and regulations determine what is needed.

Kagan’s example shows how a catalyst’s imbalance can become larger in the product. If a catalyst mixture is 75 per cent one handed form and 25 per cent the other, helpers pair randomly. The crucial idea is that matching pairs work, while mismatched pairs barely work.

The matching combinations occur in different amounts. Right-with-right pairs account for 56.25 per cent of pairings, while left-with-left pairs account for 6.25 per cent. If only those matching pairs are active, the useful pairings total 62.5 per cent. Among them, 90 per cent are right-with-right and 10 per cent are left-with-left.

So the product can become 90 per cent of the favoured form under this simplified calculation. The article’s supplied text introduces this example but cuts off before stating the numerical outcome. The result follows from the pairing mechanism it describes, illustrating a non-linear effect rather than a simple one-to-one transfer of purity.

Producing only one mirror-image form has challenged chemists for more than a century. In the 1850s, Louis Pasteur separated two kinds of tartaric-acid crystals with tweezers. He found that bacteria consumed only one kind. Yet laboratory reactions usually produced equal mixtures of the two forms.

A later step came in the early 1900s, when Willy Marckwald used a catalyst to tilt a reaction toward one mirror image. The catalyst sped the reaction without being used up, but the tilt was tiny. This showed that selective production was possible without solving the full problem of making one form overwhelmingly.

Kagan questioned the belief that catalyst purity and product purity followed a straight line. He found that mismatched helper pairs could be nearly inactive, allowing matching pairs to amplify the imbalance. Soai went further with autocatalysis, where the product helps make more of itself. These discoveries changed a small tilt into a potentially growing advantage.

Kagan’s and Soai’s work gives chemists better ways to control molecular handedness during synthesis. If a medicine needs one enantiomer, producing more of that form at the reaction stage may reduce the unwanted form that must later be separated or managed. The article connects this possibility with medicine costs and Indian manufacturing.

The mechanism is amplification. Kagan showed that mismatched catalyst-helper pairs may barely work, while matching pairs drive the reaction. Soai developed autocatalysis, in which the product also acts as the helper and speeds its own formation. A small initial preference can therefore grow into strong dominance by one mirror-image form.

The benefit is not automatic for every drug. Professor G Sekar says the need for a single form depends on safety, efficacy, and regulatory requirements. For Indian manufacturers, these discoveries could provide useful design tools for making medicines more efficiently or with fewer unwanted molecular forms where selective production is needed.

The article describes a strong biological pattern called homochirality. Amino acids exist in two mirrored forms, yet only one is found in the proteins inside cells. The sugars in DNA follow the same one-sided rule. In other words, living systems consistently use a particular molecular handedness.

The source does not explain why life developed this preference. It does show its practical consequence: cells contain structures that can distinguish mirror-image molecules. Like a right hand fitting a right hand, one molecular form may interact correctly while its twin does not. Carvone’s different spearmint and caraway smells illustrate this shape sensitivity.

This biological one-sidedness shapes modern chemistry by making selective synthesis important. Chemists use asymmetric catalysis to favour one enantiomer when a medicine requires it. Kagan’s non-linear effects and Soai’s autocatalysis offer ways to amplify a small preference instead of accepting an equal mixture.